CARPRIEVE 5 %W/V SMALL ANIMAL SOLUTION FOR INJECTION
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
25-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CARPROFEN
Available from:
Norbrook Laboratories Limited
ATC code:
QM01AE91
INN (International Name):
CARPROFEN
Dosage:
5 %w/v
Pharmaceutical form:
Solution for Injection
Prescription type:
POM
Therapeutic group:
Canine, Feline
Therapeutic area:
Carprofen
Therapeutic indications:
N.S.A.I.D
Authorization status:
Authorised
Authorization date:
2005-09-30
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprieve 5 %w/v Small Animal Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A clear colourless to pale yellow solution for injection
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and Cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In the dog: For the control of post-operative pain following orthopaedic and soft tissue surgery.
In the cat: For the treatment of post-operative pain following soft tissue surgery.
4.3 CONTRAINDICATIONS
Do not administer by intramuscular injection.
Do not administer NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to
plasma proteins and compete with other highly bound drugs, which can lead to toxic effects.
Do not use in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal
ulceration or bleeding, or hypersensitivity to the product.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Refer to statements under Sections 4.3 and 4.5.
Each ml contains :
ACTIVE SUBSTANCES
Carprofen
50
mg
EXCIPIENTS:
Benzyl Alcohol
10 mg (preservative)
Sodium Formaldehyde Sulphoxylate 2.5 mg (antioxidant)
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 31/05/2011_
_CRN 7010614_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not exceed the recommended dose or duration of treatment. In the cat, due to the longer half-life, and narrower
therapeutic index, particular care should be taken not to exceed the recommended dose.
Use in any animals less than 6 weeks of age,
Read the complete document
